New CVRx (NASDAQ: CVRX) investor urges board to prioritize a sale

Rhea-AI Filing Summary

CVRx, Inc. (CVRX) is the subject of a new Schedule 13D filed by private investor Jorey Chernett. He reports beneficial ownership of 1,461,750 shares of CVRx common stock, representing approximately 5.5% of the outstanding shares, based on 26,641,597 shares outstanding as of July 30, 2026. These shares were acquired in private transactions using personal funds totaling $7,995,772.

Chernett states he purchased the shares because he believed they were undervalued and an attractive investment. He indicates he may buy or sell additional shares, engage in hedging or derivative transactions, and actively communicate with CVRx management, the board, and other shareholders. On August 24, 2026, he delivered a letter to CVRx’s Board of Directors urging the Board to retain an independent financial advisor and initiate a review of strategic alternatives, with a sale of the company as the priority outcome.

Key Figures

Shares beneficially owned: 1,461,750 shares Ownership percentage: 5.5% Personal funds used to acquire shares: $7,995,772 +4 more

7 metrics

Shares beneficially owned 1,461,750 shares Common stock of CVRx, Inc. beneficially owned by Jorey Chernett as of August 14, 2026

Ownership percentage 5.5% Percentage of CVRx common stock beneficially owned, based on 26,641,597 shares outstanding

Personal funds used to acquire shares $7,995,772 Total personal funds used by Jorey Chernett to acquire 1,461,750 CVRx shares in private transactions

Shares outstanding 26,641,597 shares CVRx common shares outstanding as of July 30, 2026, per the company’s Form 10-Q

Sole voting power 1,461,750 shares Shares over which Jorey Chernett reports sole power to vote or direct the vote

Sole dispositive power 1,461,750 shares Shares over which Jorey Chernett reports sole power to dispose or direct the disposition

Date of strategic alternatives letter August 24, 2026 Date Chernett delivered a letter to CVRx’s Board urging a strategic review and prioritizing a sale of the company

Key Terms

Schedule 13D, beneficially owned, sole dispositive power, strategic alternatives, +1 more

5 terms

Schedule 13D regulatory

"This represents the initial statement on filed by the Reporting Person"

A Schedule 13D is a legal document that investors file with regulators when they buy a large enough stake in a company to potentially influence its management or decisions. It provides details about the investor’s intention, ownership stake, and plans, helping other investors understand who is gaining control and what their motives might be.

beneficially owned financial

"the Reporting Person beneficially owned 1,461,750 Shares"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole dispositive power financial

"Sole Dispositive Power 1,461,750.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

strategic alternatives financial

"initiate a review of strategic alternatives, with a sale of the Company"

Strategic alternatives are different options a company considers to improve its value or achieve its goals, such as selling the business, merging with another company, or restructuring operations. For investors, understanding these options is important because they can significantly impact the company's future direction and its stock value, often signaling potential changes or opportunities.

independent financial advisor financial

"urging the Board to retain an independent financial advisor and initiate"

An independent financial advisor is a professional who provides personalized investment, retirement and financial planning guidance without being tied to a single bank, insurer or product provider—think of them as an objective coach who surveys many options to fit your goals. That independence matters to investors because it reduces the chance recommendations are driven by a particular firm’s products, helps align advice with personal goals and risk tolerance, and promotes clearer disclosure of fees and trade-offs.

FAQ

What stake in CVRX does Jorey Chernett report in this Schedule 13D?

Jorey Chernett reports beneficial ownership of 1,461,750 shares of CVRx, Inc. common stock, representing approximately 5.5% of the company’s outstanding shares, based on 26,641,597 shares outstanding as of July 30, 2026.

How much has Jorey Chernett invested in CVRX shares?

Jorey Chernett acquired 1,461,750 shares of CVRx using personal funds totaling $7,995,772. The filing states these shares were purchased through private transactions funded entirely with his own capital.

Why does Jorey Chernett say he invested in CVRX (symbol CVRX)?

He states he purchased CVRx shares because he believed they were undervalued and represented an attractive investment opportunity. He intends to review his investment on a continuing basis and may adjust his position depending on market conditions and the company’s situation.

What actions is Jorey Chernett urging the CVRX Board to take?

On August 24, 2026, Chernett sent a letter urging the CVRx Board to retain an independent financial advisor and initiate a review of strategic alternatives, stating that a sale of the company should be the priority outcome of that review.

Does Jorey Chernett plan to be an active investor in CVRX (CVRX)?

Yes. He indicates he may increase or decrease his holdings, engage in communications with management and the Board, discuss potential business combinations or dispositions, propose changes to capitalization or board structure, and use hedging or derivative instruments involving CVRx shares.

What voting and dispositive power does Jorey Chernett report over CVRX shares?

He reports sole voting power over 1,461,750 shares and sole dispositive power over the same 1,461,750 shares, with no shared voting or dispositive power reported with any other person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 08:00 PM Accepted by SEC EDGAR 08/24/2026 - 08:00 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

CVRx, Inc.

(Name of Issuer)

Common Stock, $0.01 par value

(Title of Class of Securities)

126638105

(CUSIP Number)

Jorey Chernett
6222 Indianwood Tr., SUITE 650
Bloomfield Hills, MI, 48301
(248) 469-8811

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

08/24/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

schemaVersion:

SCHEDULE 13D

CUSIP Number(s): 126638105

1

Name of reporting person

Chernett Jorey

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

PF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 1,461,750.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 1,461,750.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

1,461,750.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

5.5 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Common Stock, $0.01 par value
(b)	Name of Issuer: CVRx, Inc.
(c)	Address of Issuer's Principal Executive Offices: 9201 WEST BROADWAY AVENUE, SUITE 650, MINNEAPOLIS, MINNESOTA , 55445.
Item 1 Comment: This Schedule 13D (this "Schedule 13D") is filed by the Reporting Person (as defined below) with respect to the Common Stock, $0.01 par value (the "Shares"), of CVRx, Inc., a Delaware corporation (the "Issuer"). The Reporting Person previously reported beneficial ownership of shares of the Issuer described herein on Schedule 13G, initially filed on August 14, 2026 (as amended, the "Schedule 13G"). This Schedule 13D represents the initial statement on Schedule 13D filed by the Reporting Person with the Securities and Exchange Commission (the "SEC") with respect to shares of the Issuer and amends and supersedes the Schedule 13G.
Item 2.	Identity and Background
(a)	This statement is filed by Jorey Chernett (the "Reporting Person").
(b)	The principal business address of the Reporting Person is 6222 Indianwood Trail, Bloomfield Hills, MI 48301.
(c)	The Reporting Person is a private investor.
(d)	The Reporting Person has not, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
(e)	The Reporting Person has not, during the last five years, been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
(f)	The Reporting Person is a citizen of the United States of America.
Item 3.	Source and Amount of Funds or Other Consideration
	The 1,461,750 Shares held by Mr. Chernett were acquired through private transactions using personal funds in the amount of $7,995,772.
Item 4.	Purpose of Transaction
	The Reporting Person purchased the Shares based on the Reporting Person's belief that the Shares, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Person, and the availability of Shares at prices that would make the purchase or sale of Shares desirable, the Reporting Person may endeavor to further increase or decrease his position in the Issuer through, among other things, the purchase or sale of Shares on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Person may deem advisable. The Reporting Person does not have any present plan or proposal which would relate to or result in any of the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D except as set forth herein or such as would occur upon or in connection with completion of, or following, any of the actions discussed herein. The Reporting Person intends to review his investment in the Issuer on a continuing basis. Depending on various factors including, without limitation, the Issuer's financial position and investment strategy, the price levels of the Shares, conditions in the securities markets and general economic and industry conditions, the Reporting Person may in the future take such actions with respect to his investment in the Issuer as he deems appropriate including, without limitation, engaging in additional communications with management and the Issuer's Board of Directors, engaging in discussions with stockholders of the Issuer or other third parties about the Issuer and the Reporting Person's investment, including potential business combinations or dispositions involving the Issuer or certain of its businesses, making recommendations or proposals to the Issuer concerning changes to the capitalization, ownership structure, board structure (including board composition), potential business combinations or dispositions involving the Issuer or certain of its businesses, or suggestions for improving the Issuer's financial and/or operational performance, purchasing additional Shares, selling some or all of his Shares, engaging in short selling of or any hedging or similar transaction with respect to the Shares, including swaps and other derivative instruments, or changing his intention with respect to any and all matters referred to in Item 4. On August 24, 2026, the Reporting Person delivered a letter (the "Letter") to the Board of Directors of the Issuer (the "Board") urging the Board to retain an independent financial advisor and initiate a review of strategic alternatives, with a sale of the Company as the priority outcome. A copy of the Letter is filed as Exhibit 1 to this Schedule 13D and is incorporated herein by reference.
Item 5.	Interest in Securities of the Issuer
(a)	The aggregate percentage of Shares beneficially owned by the Reporting Person is based upon 26,641,597 of the Issuer's shares of Common Stock outstanding as of July 30, 2026, as set forth in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 6, 2026. As of the close of business on August 14, 2026, the Reporting Person beneficially owned 1,461,750 Shares. Percentage: Approximately 5.5%
(b)	1. Sole power to vote or direct vote: 1,461,750 2. Shared power to vote or direct vote: 0 3. Sole power to dispose or direct the disposition: 1,461,750 4. Shared power to dispose or direct the disposition: 0
(c)	The transactions in the Shares by the Reporting Person during the past sixty days are set forth in more detail in Exhibit 2 attached hereto.
(d)	No person other than the Reporting Person is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the Shares.
(e)	Not applicable.
Item 6.	Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
	Other than as described herein, the Reporting Person does not have any other contracts, arrangements, understandings or relationships with respect to the Issuer's securities.
Item 7.	Material to be Filed as Exhibits.
	Exhibit 1: Letter from Jorey Chernett to the Board of Directors of CVRx, Inc., dated August 24, 2026. Exhibit 2: Transactions in the Securities

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Chernett Jorey

Signature:	/s/ Jorey Chernett
Name/Title:	Jorey Chernett
Date:	08/24/2026